Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives
出版年份 2015 全文链接
标题
Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 95, Issue 5, Pages 389-404
出版商
Wiley
发表日期
2015-06-19
DOI
10.1111/ejh.12610
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making
- (2015) Mark H. Eckman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Site-Level Variation in and Practices Associated With Dabigatran Adherence
- (2015) Supriya Shore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism
- (2015) Antonio Gómez-Outes et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score
- (2015) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1
- (2015) Menno V. Huisman JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
- (2015) Judith Kooiman et al. PLoS One
- Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration
- (2014) Supriya Shore et al. AMERICAN HEART JOURNAL
- Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison
- (2014) Yoon K. Loke et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
- (2014) Matthew W. Sherwood et al. CIRCULATION
- Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe
- (2014) Raffaele De Caterina et al. HEART
- Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
- (2014) Daniel Caldeira et al. JOURNAL OF NEUROLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
- (2014) Adam Cuker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Embolic strokes of undetermined source: the case for a new clinical construct
- (2014) Robert G Hart et al. LANCET NEUROLOGY
- Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain
- (2014) Antonio Gómez-Outes et al. PHARMACOECONOMICS
- New oral anticoagulant agents – general features and outcomes in subsets of patients
- (2014) Sam Schulman THROMBOSIS AND HAEMOSTASIS
- Differences among western European countries in anticoagulation management of atrial fibrillation
- (2014) Bettina Ammentorp et al. THROMBOSIS AND HAEMOSTASIS
- Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
- (2014) Antonio Gómez-Outes et al. THROMBOSIS RESEARCH
- Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013
- (2013) Gilles Pernod et al. Archives of Cardiovascular Diseases
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
- (2013) Sam Schulman et al. CIRCULATION
- Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)
- (2013) Hisao Ogawa et al. CIRCULATION JOURNAL
- Authors' response: From monitoring to vigilance about patient adherence to new oral anticoagulants
- (2013) H. Heidbuchel et al. EUROPACE
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)
- (2013) Paulus Kirchhof et al. EUROPACE
- Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs
- (2013) Amelia Troncoso et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation
- (2013) Vanessa Roldán et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
- (2013) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
- (2013) Ajay K. Kakkar et al. PLoS One
- Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
- (2013) Rikke Sørensen et al. BMJ Open
- Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial
- (2013) Daniel E. Singer et al. Journal of the American Heart Association
- Executive Summary
- (2012) Gordon H. Guyatt et al. CHEST
- Treatment and Prevention of Heparin-Induced Thrombocytopenia
- (2012) Lori-Ann Linkins et al. CHEST
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
- (2012) A. Gomez-Outes et al. BMJ-British Medical Journal
- Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
- (2011) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
- (2011) Samuel Z. Goldhaber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology
- (2010) Wiebke Gogarten et al. EUROPEAN JOURNAL OF ANAESTHESIOLOGY
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
- (2008) Alexander T Cohen et al. LANCET
- Triggers, targets and treatments for thrombosis
- (2008) Nigel Mackman NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started